Is Cure Defense Fund Legit?

Cure Defense Fund demonstrates a generally stable financial position, with assets consistently exceeding liabilities over the past decade. While revenue has fluctuated, peaking at over $5.7 million in 2015 and declining to $1.9 million in 2023, the organization has managed its expenses to maintain positive net assets. For instance, in 2023, revenue of $1,939,616 exceeded expenses of $1,795,632, contributing to an increase in net assets. The organization's financial health appears sound, with a healthy asset base of $4,677,055 in 2023. Spending efficiency is difficult to fully assess without a detailed breakdown of program, administrative, and fundraising expenses, which are not provided in the summary data. However, the consistent absence of reported officer compensation across all filings suggests a commitment to minimizing overhead in this specific area. The organization's ability to operate without direct officer compensation is a positive indicator of resource allocation. Transparency is strong regarding executive compensation, as zero officer compensation is reported across all available filings. This indicates that the organization's leadership is either unpaid or compensated through other means not categorized as officer compensation, which is a notable point for donors. Further transparency would be enhanced by publicly available detailed functional expense breakdowns.